Objective• To investigate the clinical diagnostic and prognostic value of preoperative serum
tumor markers in patients with colorectal cancer (CRC). Methods• From September 2013 to …

Background: The purpose of this study was to evaluate the significance of the combination of
the carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA19-9) levels as a …

We assessed the prognostic significance of preoperative serum carcinoembryonic antigen
(CEA), carbohydrate antigen 19-9 (CA19-9) and carbohydrate antigen 242 (CA242) levels in …

PURPOSE: CA19-9 is often used in combination with carcinoembryonic antigen to manage
patients with colorectal cancer, even though there is insufficient evidence to support this use …

Colorectal cancer (CRC) is the third most common cancer worldwide. A diagnosis at early
stages with enhanced screening methods is vital as metastases and recurrences increase …

Carcinoembryonic antigen (CEA), originally described by Gold and Freedman [1] in 1965, is
now an acknowledged member of immunoglobulin superfamily [2], with a role as an …

BACKGROUND: Carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA19-9)
are the most common tumor markers for colorectal cancer. The aim of this study was to …

Purpose Carcinoembrionic Antigen (CEA) and carbohydrate antigen 19-9 (CA 19-9) are the
most frequently used tumor markers in the clinical setting of colorectal cancer. The aim of …

Results In univariate analysis, differentiation (P< 0.001), depth of invasion (P< 0.001),
number of lymph node metastases (P< 0.001), and elevated levels of CEA (P< 0.001) and …

Carcinoembryonic antigen (CEA) and carbohydrate antigen (CA19-9) are well known tumor
markers expressed by colorectal cancer (CRC), particularly in advanced cases. In this study …